ADVFN US – Market Content Editor

  • KIDZ AI secures $44.6 million AI compute agreement with Canopy Wave (KIDZW)

    KIDZ AI secures $44.6 million AI compute agreement with Canopy Wave (KIDZW)

    Five-year GPU infrastructure contract expands AI platform strategy KIDZ AI Inc. (NASDAQ:KIDZW) has signed a definitive 60-month enterprise AI compute services agreement with Canopy Wave, Inc. valued at approximately $44.6 million, marking another step in the company’s expansion into artificial intelligence infrastructure. The agreement, announced on July 21, 2026, will be executed through KIDZ AI’s…

  • Mobileye shares climb after expanding Stellantis partnership for next-generation driver assistance (MBLY)

    Mobileye shares climb after expanding Stellantis partnership for next-generation driver assistance (MBLY)

    Cloud-based ADAS agreement boosts investor sentiment Mobileye Global Inc. (NASDAQ:MBLY) shares gained 5% on Tuesday after the company announced that its Cloud-Enhanced Advanced Driver Assist technology will be deployed in selected future Stellantis (NYSE:STLA) vehicles beginning in 2027. The collaboration will incorporate Mobileye’s REM Road Experience Management platform into certain Stellantis models, bringing enhanced cloud-powered…

  • Valmont Industries raises full-year outlook after second-quarter earnings beat (VMI)

    Valmont Industries raises full-year outlook after second-quarter earnings beat (VMI)

    Infrastructure business drives stronger-than-expected results Valmont Industries (NYSE:VMI) reported better-than-expected second-quarter results on Tuesday, beating Wall Street forecasts for both earnings and revenue as strong demand across its infrastructure operations supported growth. Shares edged 0.76% higher in pre-market trading following the announcement. Adjusted earnings came in at $6.14 per share, exceeding the analyst consensus estimate…

  • Agios shares tumble after discontinuing sickle cell disease programme following Phase 2 trial (AGIO)

    Agios shares tumble after discontinuing sickle cell disease programme following Phase 2 trial (AGIO)

    Stock drops after development setback Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) shares fell 14% on Tuesday after the company announced it will discontinue development of tebapivat for sickle cell disease following results from a Phase 2 clinical trial. The biotechnology company concluded that the study did not produce sufficiently differentiated results to justify advancing the programme. Phase…

  • Marsh & McLennan tops second-quarter forecasts as demand drives revenue growth (MRSH)

    Marsh & McLennan tops second-quarter forecasts as demand drives revenue growth (MRSH)

    Earnings beat expectations as shares edge higher Marsh & McLennan Companies (NYSE:MRSH) reported stronger-than-expected second-quarter results on Tuesday, exceeding Wall Street forecasts for both earnings and revenue as demand remained healthy across its core businesses. Shares rose 1.04% in pre-market trading following the announcement. Adjusted earnings came in at $2.96 per share, ahead of the…

  • Genuine Parts beats second-quarter expectations and maintains full-year outlook (GPC)

    Genuine Parts beats second-quarter expectations and maintains full-year outlook (GPC)

    Shares rise after earnings and revenue top forecasts Genuine Parts Company (NYSE:GPC) reported stronger-than-expected second-quarter results on Tuesday, exceeding Wall Street estimates for both earnings and revenue while reaffirming its full-year guidance. Investors responded positively to the results, sending shares of the automotive and industrial parts distributor up 3.34% in pre-market trading. Adjusted earnings came…

  • Halliburton tops second-quarter forecasts but shares fall after results (HAL)

    Halliburton tops second-quarter forecasts but shares fall after results (HAL)

    Earnings beat fails to lift the stock Halliburton Company (NYSE:HAL) reported second-quarter results ahead of market expectations on Tuesday, delivering better-than-forecast earnings and revenue despite a negative share price reaction in pre-market trading. Adjusted earnings came in at $0.55 per share, slightly above the analyst consensus of $0.54. Revenue reached $5.7 billion, exceeding expectations of…

  • Kratos shares climb after securing $156 million U.S. nuclear security contract (KTOS)

    Kratos shares climb after securing $156 million U.S. nuclear security contract (KTOS)

    Defense company wins major counter-drone programme Kratos Defense & Security Solutions (NASDAQ:KTOS) shares gained 3% on Tuesday after the company announced it had been awarded an approximately $156 million contract by the U.S. Department of Energy’s National Nuclear Security Administration Office of Secure Transportation. The sole-source Indefinite Delivery/Indefinite Quantity (IDIQ) agreement covers the delivery of…

  • Carlyle shares gain on report of Anthesis ownership discussions with Bridgepoint (CG)

    Carlyle shares gain on report of Anthesis ownership discussions with Bridgepoint (CG)

    Stock rises following report on potential transaction Shares of Carlyle Group Inc. (NASDAQ:CG) moved higher in pre-market trading on Tuesday after a report indicated the private equity firm is exploring a deal involving its investment in sustainability consultancy Anthesis Group. According to Bloomberg, Carlyle is in discussions to transfer control of Anthesis to Bridgepoint Group…

  • Vicor beats second-quarter expectations as backlog more than doubles despite share price decline (VICR)

    Vicor beats second-quarter expectations as backlog more than doubles despite share price decline (VICR)

    Earnings surpass forecasts but shares move lower Vicor Corporation (NASDAQ:VICR) reported second-quarter financial results on Tuesday that came in ahead of Wall Street expectations for both earnings and revenue. Despite the stronger-than-expected performance, the power components manufacturer’s shares declined 6.23% in pre-market trading following the release. Adjusted earnings reached $1.04 per share, comfortably exceeding the…